FDA 483 - Berkeley Biologics LLC - April 29, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Berkeley Biologics LLC in Richmond, CA, a human tissue establishment, received a Form 483 with six observations, including repeat findings. The inspection revealed significant deficiencies in donor eligibility determinations for communicable diseases, inadequate oversight of contract manufacturing partners, and failures in deviation investigations and procedural controls. Additionally, the firm used unqualified reagents and had poor environmental controls in its tissue processing areas.
ID · b334318a-9402-4bf2-aaa3-4459068b2461